MUSTANG BIO, INC. Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
MUSTANG BIO, INC. (MBIO) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $2.05 million for the 6-month period ending 2019-06-30, per its 10-Q filed 2019-08-09.
Discontinued › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2019-08-09
- MUSTANG BIO, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2019-06-30 was $126.00.
- MUSTANG BIO, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2019-03-31 was $2.05M.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month |
|---|---|---|
| 2019-06-30 | $126.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $2.05M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $2.05M 10-Q · filed 2019-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |